Press Releases

Alfa Chemistry Announces Ability to Supply Recombinant Human Collagens

CD Formulation Unveils Prominent Pharmaceutical Ingredients and Excipients for Enhanced Medicine Efficacy

Alfa Chemistry Provides Customized Synthesis Services for Biotinylation Reagents

Discovery Park Ventures invests £100K in new tenant Vox Imaging Technology to advance ophthalmic imaging for preclinical research

Discovery Park Ventures (DPV) announces an investment of £100K into Vox Imaging Technology Ltd. (VIT), an ambitious ophthalmic technology company looking to transform eye imaging in preclinical research and improve drug discovery and development. Its compact and customisable instrument is believed to be the first scanning laser ophthalmoscope especially designed for laboratory use, able to produce high-quality data rapidly.

Pharmapack Report Predicts Major Innovation for Inhaled Pulmonary and Intra Nasal Drug Delivery in 2024

Amerigo Scientific Released A Well-Selection ELISA Kits Featured with Simplicity and Consistency

Amerigo Scientific is pleased to announce the availability of their well-selection and high-quality optimized ELISA kits designed to accurately measure target-specific proteins with simplicity, reliability, and consistency.

First Health Advisory Adds Distinguished Board to Pilot Cyber Health Growth

Verisense Health Launches Research-Grade Smart Watch, Smashing Previous Price/Performance Benchmarks

Verisense Health combined its wearable technology expertise and clinical research knowledge to satisfy this unmet market need.

Johari Digital Healthcare Limited Welcomes Mr. Suhas Tamras as New Chief Executive Officer

Johari Digital Healthcare appoints Mr. Suhas Tamras as CEO. With 25+ years in medical device leadership, his proven success aligns with JDHL's commitment to excellence. Excited about global impact, Mr. Tamras pledges growth and innovation, marking a new era for JDHL.

CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry

CD BioSciences announced the launch of Chromogenic Substrates for immunohistochemistry (IHC).

Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research

Creative Diagnostics has announced P53 and TP53 antibodies and solutions to support cancer research.

Telomere Length Aging Clocks Help to See the Unseen in Aging

Rdcthera Announces RDC Development and Analysis Services Based on Its Technology Platform

STEMart Launches New Force Degradation Services to Ensure Drug Stability and Safety

STEMart announced the launch of its new Force Degradation Services.

Lifeasible Unveils Comprehensive Exosome Identification Services for Accurate Characterization and Quantification

Creative BioMart Enlarged Its Offerings for Recombinant F3 Protein

Inceptua Group and Cycle Pharmaceuticals Partner for a Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU)

Inceptua Group and Cycle Pharmaceuticals Ltd have announced a partnership to make NITYR® Tablets available via a Free Goods Programme for eligible patients with Hereditary Tyrosinemia Type 1 and Alkaptonuria.

To Fight Superbugs, Ace Infectious Unveils Phage Therapy Development Services

Alfa Chemistry Introduces Bio-based Polymers, Responding to Market Demand

CD Formulation Excels in Developing and Optimizing Micro-Reservoir Controlled-Release Drug Delivery Systems